The pharmaceutical industry jointly discusses its development plans for the 15th Five-Year Period, with increased emphasis on achieving self-sufficient supply of biological raw materials.

The pharmaceutical industry symposium focused on the high-quality development of biopharmaceuticals during the 15th Five-Year Plan period, with the achievement of self-sufficiency and controllability of upstream bioactive raw materials emerging as a key discussion topic within the industry. Urinary-derived bioactive proteins, as a niche segment, are now presenting new development opportunities.